Indian biotechs urge changes in Biotechnology Strategy

01/22/2006 | Financial Express (India), The

India's biotech industry has submitted recommendations for changing some aspects of the government's draft policy for its planned Biotechnology Strategy. Represented by the industry's CII, biotechs expressed concern the policy does not create a task force for harmonizing Indian law with other nations, which the industry feels is necessary if the country is to have a world-class regulatory and patent process.

View Full Article in:

Financial Express (India), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA